- Home
- PRZO vs EVAX Comparison
PRZO vs EVAX Comparison
Compare PRZO & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- EVAX
- Stock Information
- Founded
- PRZO 2014
- EVAX 2008
- Country
- PRZO Israel
- EVAX Denmark
- Employees
- PRZO N/A
- EVAX N/A
- Industry
- PRZO
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRZO
- EVAX Health Care
- Exchange
- PRZO Nasdaq
- EVAX Nasdaq
- Market Cap
- PRZO 13.7M
- EVAX 16.3M
- IPO Year
- PRZO 2023
- EVAX 2021
- Fundamental
- Price
- PRZO $0.60
- EVAX $1.36
- Analyst Decision
- PRZO
- EVAX Strong Buy
- Analyst Count
- PRZO 0
- EVAX 2
- Target Price
- PRZO N/A
- EVAX $10.00
- AVG Volume (30 Days)
- PRZO 340.9K
- EVAX 61.2K
- Earning Date
- PRZO 03-21-2025
- EVAX 05-27-2025
- Dividend Yield
- PRZO N/A
- EVAX N/A
- EPS Growth
- PRZO N/A
- EVAX N/A
- EPS
- PRZO N/A
- EVAX N/A
- Revenue
- PRZO $932,154.00
- EVAX $3,344,000.00
- Revenue This Year
- PRZO N/A
- EVAX $102.45
- Revenue Next Year
- PRZO N/A
- EVAX $200.44
- P/E Ratio
- PRZO N/A
- EVAX N/A
- Revenue Growth
- PRZO 50.22
- EVAX 4480.82
- 52 Week Low
- PRZO $0.49
- EVAX $1.50
- 52 Week High
- PRZO $3.16
- EVAX $22.05
- Technical
- Relative Strength Index (RSI)
- PRZO 25.11
- EVAX 27.74
- Support Level
- PRZO $0.70
- EVAX $1.67
- Resistance Level
- PRZO $0.78
- EVAX $1.97
- Average True Range (ATR)
- PRZO 0.08
- EVAX 0.12
- MACD
- PRZO -0.00
- EVAX 0.01
- Stochastic Oscillator
- PRZO 4.54
- EVAX 0.00
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.